Literature DB >> 15862084

Oxidant stress and haemolysis of the human erythrocyte.

Marco L A Sivilotti1.   

Abstract

The erythrocyte is a highly specialised cell with a limited metabolic repertoire. As an oxygen shuttle, it must continue to perform this essential task while exposed to a wide range of environments on each vascular circuit, and to a variety of xenobiotics across its lifetime. During this time, it must continuously ward off oxidant stress on the haeme iron, the globin chain and on other essential cellular molecules. Haemolysis, the acceleration of the normal turnover of senescent erythrocytes, follows severe and irreversible oxidant injury. A detailed understanding of the molecular mechanisms underlying oxidant injury and its reversal, and of the clinical and laboratory features of haemolysis is important to the medical toxicologist. This review will also briefly review glucose-6-phosphate deficiency, a common but heterogeneous range of enzyme-deficient states, which impairs the ability of the erythrocyte to respond to oxidant injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15862084     DOI: 10.2165/00139709-200423030-00004

Source DB:  PubMed          Journal:  Toxicol Rev        ISSN: 1176-2551


  22 in total

1.  Life history written in blood: erythrocyte parameters in a small hibernator, the edible dormouse.

Authors:  Nadine Havenstein; Franz Langer; Joanna Fietz
Journal:  J Comp Physiol B       Date:  2017-07-29       Impact factor: 2.200

2.  Markers of oxidative stress in senescent erythrocytes obtained from young and old age rats.

Authors:  Dileep Kumar; Syed Ibrahim Rizvi
Journal:  Rejuvenation Res       Date:  2014-10       Impact factor: 4.663

3.  Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.

Authors:  M V Relling; E M McDonagh; T Chang; K E Caudle; H L McLeod; C E Haidar; T Klein; L Luzzatto
Journal:  Clin Pharmacol Ther       Date:  2014-05-02       Impact factor: 6.875

4.  Mean remaining life span: a new clinically relevant parameter to assess the quality of transfused red blood cells.

Authors:  Denison J Kuruvilla; Demet Nalbant; John A Widness; Peter Veng-Pedersen
Journal:  Transfusion       Date:  2014-02-24       Impact factor: 3.157

5.  No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy.

Authors:  Katherine M Robinson; Wenjian Yang; Seth E Karol; Nancy Kornegay; Dennis Jay; Cheng Cheng; John K Choi; Dario Campana; Ching-Hon Pui; Brent Wood; Michael J Borowitz; Julie Gastier-Foster; Eric C Larsen; Naomi Winick; William L Carroll; Mignon L Loh; Elizabeth A Raetz; Stephen P Hunger; Meenakshi Devidas; Elaine R Mardis; Robert S Fulton; Mary V Relling; Sima Jeha
Journal:  Pediatr Blood Cancer       Date:  2019-03-07       Impact factor: 3.167

6.  Essential role for Nix in autophagic maturation of erythroid cells.

Authors:  Hector Sandoval; Perumal Thiagarajan; Swapan K Dasgupta; Armin Schumacher; Josef T Prchal; Min Chen; Jin Wang
Journal:  Nature       Date:  2008-05-04       Impact factor: 49.962

Review 7.  Markers of oxidative stress in erythrocytes and plasma during aging in humans.

Authors:  Kanti Bhooshan Pandey; Syed Ibrahim Rizvi
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

8.  PharmGKB summary: methylene blue pathway.

Authors:  Ellen M McDonagh; José M Bautista; Ilan Youngster; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2013-09       Impact factor: 2.089

Review 9.  PharmGKB summary: uric acid-lowering drugs pathway, pharmacodynamics.

Authors:  Ellen M McDonagh; Caroline F Thorn; John T Callaghan; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2014-09       Impact factor: 2.089

10.  Selective mitochondrial autophagy during erythroid maturation.

Authors:  Min Chen; Hector Sandoval; Jin Wang
Journal:  Autophagy       Date:  2008-10-01       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.